Welcome to LookChem.com Sign In|Join Free
  • or
A-967079 is a TRPA1 (Transient Receptor Potential Ankyrin 1) blocker, which is a non-selective cation channel involved in various physiological processes, including pain sensation. It is active in rat models and has been investigated for its potential in preventing neuropathic and inflammatory pain, as well as reducing cold allodynia caused by nerve injury.

1170613-55-4

Post Buying Request

1170613-55-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1170613-55-4 Usage

Uses

Used in Pharmaceutical Industry:
A-967079 is used as a potential analgesic drug for the treatment of chronic pain. It functions as a TRPA1 antagonist, which can help in managing neuropathic and inflammatory pain conditions.
Used in Pain Research:
A-967079 is used as a research tool for studying the role of TRPA1 channels in pain sensation. By blocking these channels, researchers can gain insights into the underlying mechanisms of pain and develop new therapeutic strategies.
Used in Drug Delivery Systems:
A-967079 has been used in the development of novel drug delivery systems to enhance its applications and efficacy against pain conditions. Various carriers, such as organic and metallic nanoparticles, have been employed to improve the delivery, bioavailability, and therapeutic outcomes of A-967079.
Used in Blocking miR-711-induced TRPA1 Channels:
A-967079 is used as a blocker for miR-711-induced TRPA1 channels, which may have implications in the treatment of pain related to specific genetic or molecular factors.

Biochem/physiol Actions

A-967079 is a potent and selective antagonist of Transient Receptor Potential Anykrin 1 (TRPA1) with IC50′s of 67 nM and 289 nM at human and rat TRPA1 receptors, respectively, and minimal or no activity at other TRP channels or G-protein-coupled receptors, enzymes, transporters, and ion channels out of 89 tested. A-967079 blocks TRPA1 activation in human and rat cell lines and has been shown to reduce the responses of wide dynamic range (WDR) and nociceptive specific (NS) neurons to high-intensity mechanical stimulation.

References

1) McGaraughty et al. (2010), TRPA1 modulation of spontaneous and mechanically evoked firing of spinal neurons in uninjured, osteoarthritic, and inflamed rats; Mol. Pain, 6 14.

Check Digit Verification of cas no

The CAS Registry Mumber 1170613-55-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,0,6,1 and 3 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1170613-55:
(9*1)+(8*1)+(7*7)+(6*0)+(5*6)+(4*1)+(3*3)+(2*5)+(1*5)=124
124 % 10 = 4
So 1170613-55-4 is a valid CAS Registry Number.

1170613-55-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (SML0085)  A-967079  ≥98% (HPLC)

  • 1170613-55-4

  • SML0085-5MG

  • 1,130.22CNY

  • Detail
  • Sigma

  • (SML0085)  A-967079  ≥98% (HPLC)

  • 1170613-55-4

  • SML0085-25MG

  • 4,559.49CNY

  • Detail

1170613-55-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (1E,3E)-1-(4-Fluorophenyl)-2-methyl-1-penten-3-one Oxime

1.2 Other means of identification

Product number -
Other names (1E,3E)-1-(4-Fluorophenyl)-2-methyl-1-penten-3-one oxime

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1170613-55-4 SDS

1170613-55-4Downstream Products

1170613-55-4Relevant academic research and scientific papers

TRPA1 antagonists

-

, (2015/09/22)

Compounds of formula (I) wherein R1, R2, R3, m, and Y are defined in the specification are TRPA1 antagonists. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds

TRPA1 Antagonists

-

, (2009/07/18)

Compounds of formula (I) wherein R1, R2, R3, m, and Y are defined in the specification are TRPA1 antagonists. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds an

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1170613-55-4